Shanghai Kehua Bio-engineering Co Ltd. — Investor Relations & Filings
Filings indexed
2,157
across all filing types
Latest filing
2026-04-16
Regulatory Filings
Country
CN
China
Listing
Shenzhen Stock Exchange
002022
Shanghai Kehua Bio-engineering Co., Ltd. (KHB) is a developer, manufacturer, and marketer of in vitro diagnostic (IVD) products. The company's core activities are centered on five key areas: immunodiagnostics, clinical chemistry, molecular diagnostics, mass spectrometry, and point-of-care testing (POCT). KHB provides a comprehensive range of diagnostic reagents and medical instruments to a diverse customer base that includes thousands of hospitals, disease control and prevention centers, and blood centers. The product portfolio encompasses various technologies, including ELISA, chemiluminescence immunoassays, and tests for infectious diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 未来三年股东分红回报规划（2026年-2028年） | 2026-04-16 | Chinese | |
| 独立董事2025年度述职报告（郑传芳） | 2026-04-16 | Chinese | |
| 关于举办2025年度业绩说明会的公告 | 2026-04-16 | Chinese | |
| 关于部分募投项目延期的公告 | 2026-04-16 | Chinese | |
| 第十届董事会第二十次会议决议公告 | 2026-04-16 | Chinese | |
| 关于2025年度拟不进行利润分配的公告 | 2026-04-16 | Chinese |
Browse filings by year
23 years- 2026 40 filings
- 2025 128 filings
- 2024 161 filings
- 2023 167 filings
- 2022 191 filings
- 2021 164 filings
- 2020 165 filings
- 2019 88 filings
- 2018 103 filings
- 2017 72 filings
- 2016 72 filings
- 2015 113 filings
- 2014 127 filings
- 2013 41 filings
- 2012 57 filings
- 2011 57 filings
- 2010 50 filings
- 2009 50 filings
- 2008 73 filings
- 2007 74 filings
- 2006 61 filings
- 2005 77 filings
- 2004 26 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44371952 | 未来三年股东分红回报规划（2026年-2028年） | 2026-04-16 | Chinese | ||
| 44371950 | 独立董事2025年度述职报告（郑传芳） | 2026-04-16 | Chinese | ||
| 44371947 | 关于举办2025年度业绩说明会的公告 | 2026-04-16 | Chinese | ||
| 44371945 | 关于部分募投项目延期的公告 | 2026-04-16 | Chinese | ||
| 44371942 | 第十届董事会第二十次会议决议公告 | 2026-04-16 | Chinese | ||
| 44371938 | 关于2025年度拟不进行利润分配的公告 | 2026-04-16 | Chinese | ||
| 44371935 | 2025年年度审计报告 | 2026-04-16 | Chinese | ||
| 44371928 | 关于确认董事、高级管理人员2025年度薪酬及2026年度薪酬方案的公告 | 2026-04-16 | Chinese | ||
| 44371927 | 关于购买董高责任险的公告 | 2026-04-16 | Chinese | ||
| 44371925 | 2025年度内部控制自我评价报告 | 2026-04-16 | Chinese | ||
| 44371921 | 关于开展外汇套期保值业务的可行性分析报告 | 2026-04-16 | Chinese | ||
| 44371917 | 中信证券股份有限公司关于上海科华生物工程股份有限公司2025年度募集资金存放与使用情况专项核查报告 | 2026-04-16 | Chinese | ||
| 44371912 | 2025年度营业收入扣除情况的专项审核报告 | 2026-04-16 | Chinese | ||
| 44371910 | 2025年度非经营性资金占用及其他关联资金往来情况汇总表 | 2026-04-16 | Chinese | ||
| 44371908 | 董事会关于独立董事独立性的评估意见 | 2026-04-16 | Chinese | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Shanghai Kehua Bio-engineering Co Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35671/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35671 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35671 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35671 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35671}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Shanghai Kehua Bio-engineering Co Ltd. (id: 35671)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.